LivaNova (LIVN) Total Debt (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.59% |
| Dec 31, 2025 | -13.31% |
| Sep 30, 2025 | 9.51% |
| Jun 30, 2025 | -36.90% |
| Mar 31, 2025 | 0.19% |
| Dec 31, 2024 | 0.22% |
| Sep 30, 2024 | 0.17% |
| Jun 30, 2024 | 0.11% |
| Mar 31, 2024 | 6.44% |
| Dec 31, 2023 | -0.09% |
| Sep 30, 2023 | 0.03% |
| Jun 30, 2023 | 8.21% |
| Mar 31, 2023 | 0.18% |
| Dec 31, 2022 | 0.29% |
| Sep 30, 2022 | 15.86% |
| Jun 30, 2022 | 1.81% |
| Mar 31, 2022 | 137.22% |
| Dec 31, 2021 | 18.97% |
| Sep 30, 2021 | -73.23% |
| Jun 30, 2021 | -7.94% |
| Mar 31, 2021 | 0.38% |
| Dec 31, 2020 | 0.70% |
| Sep 30, 2020 | 0.68% |
| Jun 30, 2020 | 20.00% |
| Mar 31, 2020 | 59.56% |
| Dec 31, 2019 | -1.15% |
| Sep 30, 2019 | 61.09% |
| Jun 30, 2019 | 16.99% |
| Mar 31, 2019 | 7.70% |
| Dec 31, 2018 | 7.17% |
| Sep 30, 2018 | -2.44% |
| Jun 30, 2018 | -12.19% |
| Mar 31, 2018 | 25.60% |
| Dec 31, 2017 | 17.80% |
| Sep 30, 2017 | -1.27% |
| Jun 30, 2017 | 3.29% |
| Mar 31, 2017 | -1.09% |
| Dec 31, 2016 | -15.00% |
| Sep 30, 2016 | -4.98% |
| Jun 30, 2016 | -11.34% |
| Mar 31, 2016 | -1.55% |